A phase 2 randomised study of ramucirumab (IMC-1121B) with or without dacarbazine in patients with metastatic melanoma.
European journal of cancer (Oxford, England : 1990).
Times cited: 7
- Response, survival, and prognostic factors after hepatic arterial chemoembolization in patients with liver metastases from cutaneous melanoma. Cancer Investigation. 2011 Academic Article GET IT
- Hepatic artery chemoembolization in patients with ocular melanoma metastatic to the liver: response, survival, and prognostic factors. American journal of clinical oncology. 2010 Academic Article GET IT